• Info
  • Insider Ownership

Insider Trading & Ownership of John W. Smither

Location
Westlake Village, CA
Summary
The estimated net worth of John W. Smither is at least $1,156,447 dollars as of 09 Jan 2026. John W. Smither is the Chief Financial Officer of Arcutis Biotherapeutics, Inc. and owns shares of Arcutis Biotherapeutics, Inc. (ARQT) stock worth about $540.9K. John W. Smither is the Director of NewAmsterdam Pharma Co N.V. and owns shares of NewAmsterdam Pharma Co N.V. (NAMS) stock worth about $363.6K. John W. Smither is the Director of GENELUX Corp and owns shares of GENELUX Corp (GNLX) stock worth about $252K.
Signature
/s/ Louise Kooij by Power of Attorney from John W. Smither
All Insider Reports
All Insider Reports

Notify me when John W. Smither files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of John W. Smither

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARQT Arcutis Biotherapeutics, Inc. Chief Financial Officer $540,882 13 Feb 2024
NAMS, NAMSW NewAmsterdam Pharma Co N.V. Director $363,586 07 Jan 2026
GNLX GENELUX Corp Director $251,979 27 Aug 2025
AMTI Applied Molecular Transport Inc. Director 27 Dec 2023
EFTR eFFECTOR Therapeutics, Inc. Director 22 Jun 2023

Insider Transactions Reported by John W. Smither:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.